Your browser doesn't support javascript.
loading
Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.
Kunikane, H; Watanabe, K; Fukuoka, M; Saijo, N; Furuse, K; Ikegami, H; Ariyoshi, Y; Kishimoto, S.
Affiliation
  • Kunikane H; Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama 240-8555, Japan. kunikane@courante.plala.or.jp
Int J Clin Oncol ; 6(6): 296-301, 2001 Dec.
Article in En | MEDLINE | ID: mdl-11828949
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vindesine / Antineoplastic Combined Chemotherapy Protocols / Erythropoietin / Cisplatin / Mitomycin / Carcinoma, Non-Small-Cell Lung / Anemia / Lung Neoplasms Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Japón Country of publication: Japón
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vindesine / Antineoplastic Combined Chemotherapy Protocols / Erythropoietin / Cisplatin / Mitomycin / Carcinoma, Non-Small-Cell Lung / Anemia / Lung Neoplasms Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Japón Country of publication: Japón